Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
NCT01095744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-10-07
Summary
The first objective is to asses influence of age on amyloid load measured by PET imaging using Pittsburgh B compound (PiB) radio-tracer, in Alzheimer's disease(AD). This will allow the determination of brains age-specific deterioration factors by comparing Early onset AD (EOAD), Late onset AD (LOAD)and atypical focal cortical AD (PCA and LPA). The amount of brain lesions in AD patients is estimated by:
1. measuring the rate of cortical brain atrophy,
2. FDG imaging of glucose metabolism reflecting neuronal activity, and
3. for patients who benefited from a lumbar puncture; Cortical-spinal fluid (CSF) amounts of amyloïd and tau proteins are measured.
Conditions
- Alzheimer's Disease
- Posterior Cortical Atrophy
- Logopenic Progressive Aphasia
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
lead OTHER_GOV
Principal Investigators
-
Bruno Dubois, professor doctor · INSERM U975
-
marie c sarzin, doctor · Inserm U975
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
Countries
- France
Study Locations
More Related Trials
-
Tau Imaging in Young Onset Dementia
NCT02289118 ·Status: COMPLETED
-
A Non-drug Methods Study in Participants With Alzheimer's Disease
NCT01459016 ·Status: COMPLETED ·Phase: PHASE1
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
NCT02062099 ·Status: COMPLETED ·Phase: PHASE1
-
Isotopic Imaging for Prodromal Alzheimer's Disease
NCT01231295 ·Status: COMPLETED
-
Cerebral Amyloid Imaging Using Florbetapir (AV-45)
NCT02813434 ·Status: UNKNOWN ·Phase: PHASE3
-
Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults
NCT03129269 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects
NCT00951197 ·Status: COMPLETED
-
Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases
NCT06731842 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Amyloïd Load in Elderly Population: Effect of Cognitive Reserve
NCT02196116 ·Status: UNKNOWN ·Phase: NA
-
Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD
NCT02681172 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease
NCT05911178 ·Status: RECRUITING ·Phase: NA
-
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers
NCT01826110 ·Status: COMPLETED ·Phase: PHASE1
-
18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study
NCT02556502 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid
NCT00692705 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
NCT05456503 ·Status: RECRUITING ·Phase: PHASE3
-
Memory Imaging of Normal Aging
NCT00315575 ·Status: COMPLETED
-
Modelling in the Quantitative Analysis of Brain PET Scans in Patients With Alzheimer's Disease
NCT04718207 ·Status: COMPLETED
-
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281 ·Status: COMPLETED ·Phase: NA
-
PET Study With 11 C-PIB to Evaluate Amyloid Protein Deposits in Mild Cognitive Disorder, Alzheimer's Disease and Early Frontotemporal Degeneration.
NCT06179979 ·Status: COMPLETED
-
Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)
NCT06467981 ·Status: COMPLETED
-
Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants
NCT02187627 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.
NCT03863041 ·Status: COMPLETED ·Phase: NA
-
Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging
NCT02494531 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1